MALAT1 and colorectal carcinoma: Wu and colleagues recently looked into the possibility that Jumonji domain 2 (JMJD2) might epigenetically control the promoter activity of MALAT-1 and the downstream β-catenin signaling pathway, consequently impacting the ability of CRC cells to spread [93].